oxycodone has been researched along with trk 820 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 6 (85.71) | 2.80 |
| Authors | Studies |
|---|---|
| da Silva, FS; do Carmo, JM; Edwards, SR; Freeman, KB; Hall, JE; Kapanda, CN; McCurdy, CR; McLendon, HW; Naylor, JE; Negus, SS; Qureshi, HN; Sufka, KJ; Townsend, EA | 1 |
| Freeman, KB; Huskinson, SL; Naylor, JE; Prisinzano, TE; Townsend, EA; Zamarripa, CA | 1 |
| Blough, BE; Brasfield, M; Follett, ME; Freeman, KB; Huskinson, SL; Platt, DM; Prisinzano, TE | 1 |
| Kreek, MJ; Zhang, Y | 1 |
| Freeman, KB; Pareek, T; Patel, TR; Prisinzano, TE; Schrock, HM; Williams, BC; Zamarripa, CA | 1 |
| Blough, BE; Brasfield, M; Dunaway, K; Freeman, KB; Huskinson, SL; Platt, DM; Prisinzano, TE; Zamarripa, CA | 1 |
| Doyle, WS; Dunaway, K; Freeman, KB; Huskinson, SL; Platt, DM; Prisinzano, TE; Smith, ZR; Zamarripa, CA | 1 |
7 other study(ies) available for oxycodone and trk 820
| Article | Year |
|---|---|
Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats.
Topics: Analgesics; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Male; Models, Animal; Morphinans; Nociception; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Reinforcement, Psychology; Respiration; Self Administration; Spiro Compounds | 2017 |
Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Cocaine; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Macaca mulatta; Male; Morphinans; Naltrexone; Narcotic Antagonists; Oxycodone; Receptors, Opioid, kappa; Reinforcement, Psychology; Self Administration; Spiro Compounds | 2020 |
Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Behavior, Animal; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Macaca mulatta; Male; Morphinans; Motor Activity; Oxycodone; Receptors, Opioid, kappa; Spiro Compounds | 2020 |
Nalfurafine modulates the reinforcing effects of oxycodone in male and female adolescent C57BL/6J mice.
Topics: Age Factors; Analgesics, Opioid; Animals; Behavior, Addictive; Conditioning, Psychological; Female; Male; Mice; Mice, Inbred C57BL; Morphinans; Oxycodone; Receptors, Opioid, kappa; Reinforcement, Psychology; Self Administration; Spiro Compounds | 2020 |
The kappa-opioid receptor agonist, nalfurafine, blocks acquisition of oxycodone self-administration and oxycodone's conditioned rewarding effects in male rats.
Topics: Analgesics, Opioid; Animals; Conditioning, Classical; Dose-Response Relationship, Drug; Male; Morphinans; Opioid-Related Disorders; Oxycodone; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, kappa; Reinforcement, Psychology; Reward; Self Administration; Spiro Compounds; Substance-Related Disorders | 2020 |
The G-protein biased kappa opioid agonists, triazole 1.1 and nalfurafine, produce non-uniform behavioral effects in male rhesus monkeys.
Topics: Analgesics, Opioid; Animals; GTP-Binding Proteins; Hypnotics and Sedatives; Macaca mulatta; Male; Morphinans; Oxycodone; Receptors, Opioid, kappa; Spiro Compounds; Triazoles | 2022 |
Quantification of observable behaviors following oral administration of oxycodone and nalfurafine in male rhesus monkeys.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Humans; Macaca mulatta; Male; Oxycodone; Receptors, Opioid, kappa | 2023 |